These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26109723)

  • 1. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
    Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
    J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
    Liu J; Martin HJ; Liao G; Hayward SD
    J Virol; 2007 Oct; 81(19):10451-9. PubMed ID: 17634226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.
    Fujimuro M; Hayward SD
    J Virol; 2003 Jul; 77(14):8019-30. PubMed ID: 12829841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation.
    Liu J; Martin H; Shamay M; Woodard C; Tang QQ; Hayward SD
    J Virol; 2007 May; 81(9):4722-31. PubMed ID: 17314169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.
    Fujimuro M; Liu J; Zhu J; Yokosawa H; Hayward SD
    J Virol; 2005 Aug; 79(16):10429-41. PubMed ID: 16051835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
    Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
    J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
    Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
    Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the chromatin binding domain of KSHV LANA.
    Woodard C; Shamay M; Liao G; Zhu J; Ng AN; Li R; Newman R; Rho HS; Hu J; Wan J; Qian J; Zhu H; Hayward SD
    PLoS Pathog; 2012; 8(10):e1002972. PubMed ID: 23093938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D; Guasparri I; Cesarman E
    Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
    Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
    PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
    Fujimuro M; Wu FY; ApRhys C; Kajumbula H; Young DB; Hayward GS; Hayward SD
    Nat Med; 2003 Mar; 9(3):300-6. PubMed ID: 12592400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
    Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
    J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
    Cai Q; Murakami M; Si H; Robertson ES
    J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
    Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
    FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.
    Cai QL; Knight JS; Verma SC; Zald P; Robertson ES
    PLoS Pathog; 2006 Oct; 2(10):e116. PubMed ID: 17069461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
    Si H; Robertson ES
    J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.
    Qin D; Feng N; Fan W; Ma X; Yan Q; Lv Z; Zeng Y; Zhu J; Lu C
    BMC Microbiol; 2011 Oct; 11():240. PubMed ID: 22032493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
    Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
    Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
    Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
    J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.